4//SEC Filing
Klingensmith Harvey Robert 4
Accession 0001209191-21-025318
CIK 0001000229other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:53 PM ET
Size
10.6 KB
Accession
0001209191-21-025318
Insider Transaction Report
Form 4
Klingensmith Harvey Robert
Director
Transactions
- Exercise/Conversion
Restricted Shares
2021-04-01−14,507→ 0 totalExercise: $0.00→ Common Shares (14,507 underlying) - Award
Restricted Shares
2021-04-01+4,307→ 4,307 totalExercise: $0.00→ Common Shares (4,307 underlying) - Exercise/Conversion
Common Shares
2021-04-01+14,507→ 16,507 total - Tax Payment
Common Shares
2021-04-01$30.10/sh−73$2,197→ 16,434 total
Footnotes (2)
- [F1]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2021.
- [F2]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2022, subject to the terms of issuance.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001800107
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 5:53 PM ET
- Size
- 10.6 KB